Publication:
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.

Simple item page
dc.contributor.authorTopcu, Atakan
dc.contributor.authorAtci, Muhammed Mustafa
dc.contributor.authorSecmeler, Saban
dc.contributor.authorBesiroglu, Mehmet
dc.contributor.authorAyhan, Murat
dc.contributor.authorOzkan, Metin
dc.contributor.authorBozkurt, Oktay
dc.contributor.authorUrakci, Zuhat
dc.contributor.authorAy, Seval
dc.contributor.authorGeredeli, Caglayan
dc.contributor.authorYasin, Ayse Irem
dc.contributor.authorTurk, HACI MEHMET
dc.contributor.institutionauthorTÜRK, HACI MEHMET
dc.date.accessioned2021-08-03T20:59:09Z
dc.date.available2021-08-03T20:59:09Z
dc.date.issued2021-07-29T00:00:00Z
dc.identifier.citationTopcu A., Atci M. M. , Secmeler S., Besiroglu M., Ayhan M., Ozkan M., Bozkurt O., Urakci Z., Ay S., Geredeli C., et al., -Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.-, Future oncology (London, England), 2021
dc.identifier.doi10.2217/fon-2021-0398
dc.identifier.pubmed34323116
dc.identifier.urihttp://hdl.handle.net/20.500.12645/29103
dc.titleEfficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id17b53708-d325-45be-b7dc-8c1371566452
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isAuthorOfPublication.latestForDiscovery1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler